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Abstract 
Dengue virus (DENV) causes the most prevalent arthropod-borne viral disease of humans 
worldwide. Glycosphingolipids (GSLs) are involved in virus infection by regulating various steps of 
viral-host interaction. However, the distinct role of GSLs during DENV infection remains unclear. 
In this study, we used mouse melanoma B16 cells and their GSL-deficient mutant counterpart 
GM95 cells to study the influence of GSLs on DENV infection. Surprisingly, GM95 cells were highly 
resistant to DENV infection compared with B16 cells. Pretreatment of B16 cells with synthetase 
inhibitor of GM3, the most abundant GSLs in B16 cells, or silencing GM3 synthetase T3GAL5, 
significantly inhibited DENV infection. DENV attachment and endocytosis were not impaired in 
GM95 cells, but DENV genome replication was obviously inhibited in GM95 cells compared to B16 
cells. Furthermore, GM3 was colocalized with DENV viral replication complex on endoplasmic 
reticulum (ER) inside the B16 cells. Finally, GM3 synthetase inhibitor significantly reduced the 
mortality rate of suckling mice that challenged with DENV by impairing the viral replication in 
mouse brain. Taken together, these data indicated that GM3 was not required for DENV 
attachment and endocytosis, however, essential for viral genome replication. Targeting GM3 could 
be a novel strategy to inhibit DENV infection. 
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Background 
Dengue virus (DENV) is a mosquito-borne 
pathogen responsible for outbreaks of dengue fever 
(DF), dengue hemorrhagic fever (DHF), and dengue 
shock syndrome (DSS). DENV is widely distributed 
in subtropical and tropical areas of the world and 
infect 50–100 million individuals every year[1, 2]. 
However, there is no specific antiviral drug against 
DENV[3, 4]. 
Like other flaviviruses, DENV is internalized via 
receptor-mediated endocytosis[5-7]. Then the viral 
genome is released and translated at the rough 
endoplasmic reticulum (ER) to produce a polyprotein, 
which is cleaved into three structural proteins (the 
capsid protein C, membrane protein M, and the 
envelope protein E), and seven nonstructural proteins 
(NS1, NS2A, NS2B, NS3, NS4A, NS4B and NS5)[6, 8]. 
After initial translation, viral RNA replication takes 
place in a structure called replication complex (RC) on 
the ER membranes. RC is composed of viral RNA, 
nonstructural proteins and other host factors[9-11]. 
DENV NS4A induced ER membrane alterations, 
which may serve as a scaffold to anchor the viral RC 
[12]. Some flaviviruses have been reported to exploit 
cellular lipids to assemble their RC[13]. For example, 
HCV RNA replication occurs on the membranous 
web (MW) containing the high levels of cellular lipid 
phosphatidylinositol-4-phosphate (PI4P)[14]. DENV 
NS3 recruited fatty acid synthase (FASN) to the sites 
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of DENV replication, resulting in lipid 
biosynthesis[15]. West Nile virus (WNV) redistributes 
cholesterol to the sites of viral replication[16]. 
However, mechanisms of cellular lipids involved in 
DENV replication complex formation remain largely 
unclear. 
Glycosphingolipids (GSLs), amphipathic 
molecules consisting of a ceramide and sugar 
residues, are ubiquitous cellular components of 
eukaryotic plasma membranes[17-19]. Besides of the 
roles in cell adhesion and signal transduction, GSLs 
have been shown to participate in various stages of 
life cycle of distinct viruses[20, 21]. Most of the current 
reports focused on the role of GSLs and their 
metabolites on the virus attachment and entry of 
specific cells[20, 21]. For example, galactosylceramide 
(GalCer) and sulfatide interact with HIV gp120 or 
gp41, and act as an alternate receptor for HIV in 
CD4-negative cells[22]; GD1a and GT1b are used as 
entry receptors by murine polyoma virus[23]; 
Gangliosides are ligands for human noroviruses 
(NoVs)[24], rotaviruses[25] and parvovirus B19[26]. 
Gangliosides are required for productive cell entry of 
rotaviruses[25], and ceramide also plays roles in entry 
and egress processes of Japanese encephalitis virus 
(JEV)[27].  
As GSLs have biophysical properties of 
membrane bending and stretching, they are also 
involved in viral maturation and budding[20, 21]. For 
example, HIV-1 selectively assemble and bud from 
GSL-enriched lipid microdomains, resulting in 
incorporation of GSL into the viral membrane[28]. A 
recent study by Konan and colleagues showed that a 
GSL -binding protein, FAPP2, recruited GSLs to the 
HCV replication complex, and critical for modulation 
of HCV genome replication[14]. However, the distinct 
role of GSLs on DENV infection is unclear.  
GM95 is a mutant cell line of B16 cells that do not 
synthesize GSLs including GM3 due to deficient in 
ceramide glycosyltransferase (GlcT-1), the first step of 
glucosylceramide (GlcCer) synthesis[29]. As GM3 is 
the most abundant GSLs in B16 cells, we focus on the 
function of GM3 on DENV replication in the present 
study. 
Methods 
Ethics Statements- All animal experiments were 
conducted according to the Guide for the Care and 
Use of Medical Laboratory Animals (Ministry of 
Health, People’s Republic of China, 1998) and 
approved by the Animal Care and Use Committee as 
well as the Ethical Committee of Soochow University.  
Virus, cells and replicons- DENV type 2 
(DENV-2) New Guinea C (NGC) strain was 
propagated in mosquito C6/36 cells (from ATCC® 
CRL-1660). B16 and GM95 cells were initially from Dr. 
Steven B Levery (University of New Hampshire) and 
maintained in our lab in DMEM supplemented with 
10 %( v/v) FBS and 1 %( v/v) penicillin-streptomycin. 
Cells were infected with DENV-2 at a multiplicity of 
infection (MOI) of 1, unless otherwise stated. 
DNA-based replicons (for DENV type 1) expressing 
secreted Gaussia luciferase (DGL2 and DGL2-mut) 
[30], were generously provided by Dr. Takayuki 
Hishiki (Kyoto University, Kyoto, Japan). 
Inhibitors and antibodies- Pharmacological 
inhibitors 1-phenyl-2-palmitoylamino-3-morpholino- 
1-propanol (PPMP) and Soyasaponin-I were 
purchased from Sigma Aldrich. Primary antibodies 
Mouse anti-DENV (Santa Cruz), mouse 
anti-GM3 (NeuAc) mAb M2590 (Cosmo Bio Co. Ltd, 
Tokyo, Japan) and secondary antibodies FITC labeled 
Donkey anti-mouse IgG (Jackson ImmunoResearch), 
Goat anti-Mouse IgM Secondary Antibody, FITC 
conjugate (Pierce) were used in this study. 
TCID50 assay and viral growth kinetics- B16 
and GM95 cells were seeded in 24-well plate and 
infected with DENV for 12, 24 and 48 hrs, 
respectively. The cell-free supernatants were collected 
and the DENV titers were assayed with a TCID50 
assay according to standard protocols on Vero cells 
(ATCC® CCL-81). The viral replication levels inside 
cells, in terms of the transcript levels of the DENV-2 
envelop gene (E), were quantified by quantitative 
reverse transcription PCR (qRT-PCR) and normalized 
to mouse beta actin gene.  
Preparation of Rhodamine-labeled DENV- 
Viruses were concentrated by ultracentrifugation and 
then labelled with Rhodamine dye using 
a NHS-Rhodamine antibody labelling kit (Pierce) 
according to manufacturer's protocol. Briefly, purified 
viruses were dialyzed in 0.67M borate buffer and 
incubate in the dark at room temperature with 
NHS-Rhodamine Reagent. After 1 hr, the 
unincorporated dye was removed by resin filter. 
Rhodamine-Labelled viruses were used immediately. 
Virus binding and endocytosis assay- For virus 
binding assay, B16 and GM95 cells were incubated 
with DENV (MOI=10) at 4 ℃ for 1 hr. The cells were 
washed three times with pre-cold PBS to remove 
unbound viruses. Two approaches were used to 
determine the virus binding efficiency: (a) cells were 
lysed directly for qRT-PCR analysis of virus E gene 
copy; (b) cells were lysed and the number of bound 
virus was measured by TCID50 assay. 
To assess viral internalization efficiency (virus 
endocytosis assay), B16 and GM95 cells were 
incubated with DENV (MOI=10) at 37 ℃ for 30 min. 
Cells were washed with PBS and treated with 0.5% 
trypsin for 10 min to remove the viruses that not 
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internalized. Finally, cells were washed with PBS and 
harvested by low-speed centrifugation. Intracellular 
viral RNA was quantified by qRT-PCR. 
For a visualized DENV binding and endocytosis 
assay, the same experimental procedure was 
performed using a Rhodamine-labeled DENV as 
described above. Cells were incubated with labelled 
virus for 1 hr at 4 ℃ (for virus binding) or incubated at 
37 ℃ for 30 min (for virus internalization). Cells were 
fixed in 4% formaldehyde, permeabilized with 0.1% 
Triton X-100 and then examined by inverted 
fluorescence microscope (cell nucleus were 
stained with DAPI). 
RT-PCR of virus negative strand RNA 
(-ssRNA)- To generate the cDNA template specific for 
DENV negative strand RNA, the total RNA was 
extracted from DENV-infected cells at 6, 12 and 24 hr 
postinfection. Forward PCR primer for DENV E gene 
was used to transcribe the cDNA for negative strand 
RNA using First Strand cDNA Synthesis Kit 
(Thermo). DENV E gene and mouse beta actin were 
amplified by PCR with rTaq DNA polymerase 
(TaKaRa Biotechnology), and detected by 
electrophoresis on a 2% agarose gel. 
DENV replicon Gaussia luciferase reporter 
assay- In 48-well plates, 50% confluent B16 and GM95 
cells were transfected with 100 ng of DGL2-WT or 
DGL2-mut replicon plasmids. For the Gaussia 
luciferase assay, culture supernatant were collected at 
different time points ( 0, 24, 48, 72 and 96 hr post 
transfection) and luciferase was measured using 
BioLux™ Gaussia Luciferase Assay Kit (New England 
Biolabs) according to the manufacturer’s instructions.  
RNA interference and qRT-PCR- siRNA 
targeting mouse T3gal5 gene and negative controls 
were ordered from Ribotask (Guangzhou, China). B16 
cells were seeded in 24-well plates prior to 
transfection and the siRNA were transfected into cells 
using Lipofectamine 2000 (Invitrogen) according to 
the manufacturer's protocol. After 24 
hrs, siRNA-transfected cells were then infected with 
DENV. Viral replication were measured by 
amplifying the DENV-2 E gene and normalized to 
mouse beta actin. (siRNA and oligo-primer sequences 
for this study were shown in Table S1 in the 
supplemental materials). 
Pharmaceutical inhibitors treatment and cell 
viability assay- Two inhibitors were used for 
inhibiting ganglioside biosynthesis. PPMP, an 
inhibitor of glucosylceramide synthase that catalyses 
the first step of ganglioside biosynthesis; 
Soyasaponin-I, a sialyltransferase inhibitor, inhibits 
the last step of synthesis of GM3. B16 cells were 
cultured in 48-well plates, 1μM PPMP (or 100 μM 
Soyasaponin-I) was added to cells. At 48 hr post 
treatment, cells were washed three times with PBS 
and then infected with DENV. The viral replication 
efficiency was measured as described above.  
For cell viability assay, B16 cells were cultivated 
in 96-well plates to 90% confluency and treated with 
the inhibitor compounds as described concentration 
above. Following treatment at 37 °C for 48 hrs, cell 
viability was evaluated using the CellTiter-Glo® 
Luminescent Cell Viability Assay (Promega) 
according to the manufacturer’s instructions. 
Addition of exogenous GM3 to GM95 cells- To 
evaluate the effect of exogenous ganglioside GM3 on 
GM95 cells during DENV infection, GM3 (bovine, 
purity >98%, from Matreya LLC.) was added to the 
GM95 culture medium at a final concentration of 100 
μg/μl. Unincorporated gangliosides were removed 
by washing twice with 20% FBS-DMEM prior to 
DENV infection. Then, the cells were infected with 
DENV-2 and viral replication efficiency was 
measured as described above. 
Immunofluorescence staining and confocal 
microscopy- B16 and GM95 cells grown on 48-well 
plate were infected with DENV-2. At 24 hr 
postinfection, the cells were fixed with 4% 
paraformaldehyde (PFA) for 10 min, permeabilized 
with 0.1% Triton X-100 in PBS, and then blocked with 
5% FBS in PBS. Plates were incubated with a DENV 
envelope monoclonal antibody overnight at 4 °C, 
washed, and then incubated with FITC goat 
anti-mouse secondary antibody for 1 hr at room 
temperature. Samples were analyzed by an inverted 
fluorescence microscope. 
To analyze of the changes of GM3 in B16 cells 
upon DENV infection, DENV-2 infected or 
non-infected B16 cells were fixed and immunostained 
with antibody against GM3. Then images were 
collected using confocal fluorescence microscopy. 
For co-localization study, B16 cells were 
transfected with YFP-KDEL (an ER lumen protein) 
and infected with DENV-2. 48 hr postinfection, cells 
were fixed with 4% PFA. DENV NS4A protein and 
GM3 were probed with primary antibodies (rabbit 
IgG anti-DENV NS4A and mouse anti-GM3 mAb ) 
and stained with Dy light 649 donkey anti-rabbit IgG 
and TRITC labeled anti-mouse IgM, respectively. The 
localizations of DENV NS4A, GM3 and ER inside cells 
were then examined by confocal microscope. 
GSL extraction, Mass Spectrometry, and 
thin-layer chromatography (TLC)- GSLs extraction 
was performed as described previously[31]. Briefly, 
cell pellets (1x108) were extracted by sonication with 
each of the following different solvents: (i) 
chloroform/methanol (1:1, v/v); (ii) isopropanol/ 
hexane/water (55:25:20, v/v/v). Supernatants were 
dried and whole lipids were dissolved with 
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chloroform/methanol/water (30:60:8, v/v/v) and 
then applied to a DEAE Sephadex A-25 (Sigma, St. 
Luis, MO, USA) on a glass column (Internal 
diameter×Length, 5×80 mm) for separation of neutral 
and acidic lipid fraction. The acidic lipid fraction was 
dried, dialyzed and lyophilized. 
GSLs were completely methylated as described 
previously[31, 32]. Methylated GSLs were analyzed 
by LTQ-XL mass spectrometer (Thermo Fischer 
Scientific, Waltham) in the positive ion mode ( ion 
spray voltage 3.5 kV, capillary voltage 35 V, capillary 
temperature 350 ℃, injection time 100 ms, activation 
time 30 min, and isolation width m/z 1.5). 
Acid GSLs were further analyzed by thin-layer 
chromatography (TLC) as described [29]. The purified 
acid GSLs were developed on TLC plates of silica gel 
60 (Merck) with chloroform/methanol/0.25% 
CaCl2˙H2O (50:40:10, v/v/v). The plate was sprayed 
with a resorcinol/H2SO4 reagent and then heated at 
110 ℃ for 30 min. The purified ganglioside GM3 
(Matreya LLC, Pleasant Gap, PA, USA) was used as 
standard. 
DENV infection of suckling mice- Breeder 
BALB/c mice were purchased from Shanghai SLAC 
Laboratory animal CO. LTD. Each 3- or 4-day-old 
suckling mouse was inoculated intracerebrally with 
100 PFU of DENV-2 as previously described[33], 
together with or without 15 μg of GM3 synthetase 
inhibitor soyasaponin-I. Survival of 
mice were monitored daily and the 
DENV replication level in cerebrum at 
day 2 and day 4 postinfection were 
measured by qRT-PCR method 
described above.  
Statistical analysis- Statistical 
significances were calculated with an 
unpaired two tailed Student’s t- test 
and Log-rank (Mantel-Cox) Test (for 
survival data only) using Prism 5 
software (GraphPad). 
Results 
GM95 cells are resistant to 
DENV infection  
GM95 cells, a mutant B16 
melanoma cell line, are incapable of 
synthesizing GSLs due to a defective 
GlcT-1 gene. As shown in Fig. 1A, 
GSL GM3 was highly expressed in 
wild type cells, but not in GM95 cells. 
 
 
Figure 1. GM95 cells were resistant to DENV 
infection. (A) Immunofluorescence analysis of GM3 in B16 
and GM95 cells. B16 and GM95 cells were fixed and 
immunostained with GM3 monoclonal antibody. The images 
were collected using confocal fluorescence microscopy. (B) 
Growth curves of DENV-2 in B16 and GM95 cells. The viral 
burdens were analyzed by measuring the virus E gene copy 
using qRT-PCR, and normalized to mouse beta actin. (C) 
B16 and GM95 cells were seeded in 24-well plate and 
infected with DENV for 12, 24 and 48hrs, respectively. The 
cell-free supernatants were collected and the DENV titers 
were assayed with a TCID50 assay on Vero cells. Results 
were expressed as the mean + the SEM. * p < 0.05 and ** p 
< 0.01 (t-test). Representative results from at least 3 
independent experiments. (D) The supernatants from Fig. 
1C were used to test cell pathogenic effect (CPE) on Vero 
cells. Supernatants from infected B16 cells, but not from 
infected GM95 cells, had significantly cell pathogenic effect 
on Vero cells. 
 
 
  
Int. J. Biol. Sci. 2016, Vol. 12 
 
 
http://www.ijbs.com 
876 
To determine the roles of GSLs on DENV 
infection, we exposed the B16 and GM95 cells to 
DENV-2. Viral infection level was measured by 
amplifying the viral envelope gene (E) copies using 
qRT-PCR at 0, 24, 48 and 72 hr postinfection and 
normalized to mouse beta-actin gene. As shown in 
Fig. 1B, B16 cells were highly susceptible to DENV 
infection, while GM95 cells were resistant to DENV 
infection. To further test whether GSLs impact 
production of infectious virus particles, the titers of 
virus in the supernatant of infected B16 and GM95 
cells were measured by TCID50 assay. The numbers 
of DENV virions in cell supernatants from GM95 cells 
were much lower than that from B16 cells (Fig. 1C). As 
shown in Fig. 1D, supernatants from infected B16 cells 
caused significantly cell pathogenic effect (CPE) on 
Vero cells. However, supernatants from infected 
GM95 cells did not cause noticeable cell death. Taken 
together, these data suggested that GM95 cells were 
resistant to DENV infection. 
Inhibition of GM3 synthesis impedes DENV 
infection 
To inhibit GSLs metabolism, inhibitors PPMP 
and Soyasaponin-I were used to treat B16 cells. PPMP 
is a glucosylceramide synthase inhibitor, and deplete 
GSLs production by inhibiting GlcT-1 activity. 
Soyasaponin-I, a specific sialytransferase inhibitor, 
inhibits the last step of synthesis of GM3. As shown in 
Fig. 2A and B, DENV RNA levels were reduced more 
than 50% following the treatment of PPMP or 
Soyasaponin-I. We have verified that the inhibitor 
treatment has a negligible impact on cell viability as 
determined using the CellTiter-Glo Luminescent Cell 
Viability Assay (Promega) (Fig. 2C and D). To further 
confirm the role of GM3 on DENV infection, GM3 
synthetase was silenced by siRNA targeting mouse 
T3gal5 gene (mt3gal5) (Fig. 2E). Consistent with the 
data shown in Fig. 2B, the intracellular viral loads 
were decreased in GM3 synthetase knockdown cells 
(Fig. 2F). Moreover, exogenous ganglioside GM3 
added to GM95 cells partially restored the DENV 
infection (Fig. 2G). These data suggested that 
GM3 played important roles in DENV 
infection. 
 
 
Figure 2. Inhibition of GM3 synthesis impeded DENV infection. 
(A) A glucosylceramide synthase inhibitor, PPMP, inhibited DENV 
replication in B16 cells. (B) Soyasaponin-I, the GM3 synthetase inhibitor, 
inhibited DENV replication in B16 cells. (C, D) Viability of B16 cells treated 
with PPMP (C) or Soyasaponin-I (D). (E) The RNAi efficiency of mt3gal5 
siRNA was tested in B16 cells. (F) DENV replication was inhibited in 
mt3gal5 knockdown B16 cells. (G) Exogenous ganglioside GM3 added to 
GM95 cells partially restored the DENV infection. Results were expressed 
as the mean + the SEM. * p < 0.05 and ** p < 0.01 (t-test). Representative 
results from at least 3 independent experiments. 
 
GM3 synthesis is upregulated in DENV 
infected cells 
To explore whether the expression of 
GM3 changed upon DENV infection, 
immunofluorescence assay was performed 
with immunofluorescence staining using GM3 
mAbs in B16 cells. As shown in Fig. 3A, the 
production of GM3 was significantly higher in 
DENV infected B16 cells. The result was 
further confirmed by mass spectrometry and 
thin layer chromatography analysis. As shown 
in Fig. 3B, the GM3 specific m/z peaks (1358.00 
and 1468.08) were significantly higher in 
infected B16 cells compared with non-infected 
cells. In a TLC analysis, the fraction of GM3 
was increased in the infected cells compared 
with non-infected cells (Fig. 3 C and D). In line 
with these results, the mRNA level of GM3 
synthetase gene mT3gal5 in B16 cells was 
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significantly increased post DENV infection as 
determined by qRT-PCR and normalized to mouse 
beta-actin gene (Fig. 3E). These data suggested that 
GM3 production was increased in DENV infected B16 
cells, further indicating that GM3 is important in 
DENV infection.  
GM3 does not influence binding and 
endocytosis of DENV 
To assess whether the GM3 was necessary in 
early stage of viral infection, the amount of 
membrane-bound and internalized viruses were 
measured by qRT-PCR of virus E gene and 
Rhodamine-labeled virus imaging. The amount of 
viruses attached to B16 and GM95 cells was also 
analyzed by TCID50 assay on Vero cells. For virus 
binding assay, B16 and GM95 cells were incubated 
with DENV (MOI=10) at 4 ℃ for 1 hr. The results 
suggested that no significant differences in the 
efficiency of virus binding between B16 and GM95 
cells (Fig. 4, A-C). To quantity the viruses that entered 
into the cells, the viruses were incubated with cells at 
37 ℃ for 30 min and then the cells were treated with 
trypsin. As shown in Fig. 4D and 4E, trypsin, but not 
PBS, could effectively remove the virions which just 
binding to the cell membrane. After trypsin treatment, 
the viral RNA could still be detected in GM95 cells, 
with a comparable level of those in B16 cells (Fig. 4F). 
The Rhodamine-labeled DENV were also obviously 
detected inside the GM95 cells in the virus 
endocytosis assay (Fig. 4G). These results suggested 
that GM3 was not involved in the virus binding and 
internalization.  
 
 
Figure 3. GM3 synthesis was upregulated in DENV infected cells. (A) Immunofluorescence analysis of GM3 in DENV infected and non-infected B16 cells. GM3 mouse 
mAb and DENV NS3 mAb were used to perform the experiment. (B) Mass spectrometry analysis of GSLs in DENV infected and non-infected B16 cells. Both m/z peaks (1358.0 
and 1468.08) represented GM3. (C) The GM3 fractions from DENV-infected and noninfected B16 cells were detected on TLC plates. Purified GM3 were served as a standard. 
(D) Relative amount of GM3 fractions from Fig. 3C by density analysis. (E) The mRNA expression level of GM3 synthetase mt3gal5 at different time points after DENV infection, 
normalized to mouse beta actin gene. Results were expressed as the mean + the SEM. * p < 0.05 and ** p < 0.01 (t-test). Representative results from at least 3 independent 
experiments. 
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Figure 4. GM3 was not necessary for DNEV binding and endocytosis. (A, B) B16 and GM95 cells were incubated with DENV (MOI=10) at 4 ℃ for 1 hr. The cells were 
washed three times with pre-cold PBS to remove unbound viruses. The amount of membrane-bound DENV as measured by qRT-PCR of DENV E gene RNA (A) and TCID50 
assay (B). (C) 4 ℃ binding assay with Rhodamine-labeled DENV in B16 and GM95 cells (cell nucleus were stained with DAPI). (D, E) The amount of viral RNA copies in B16 (D) 
and GM95 (E) cells with or without trypsin treatment. The results confirmed that trypsin treatment could efficiently remove DENV virions that not been internalized. (F) The 
amount of internalized DENV in B16 cells and GM95 cells as measured by qRT-PCR of DENV E gene RNA. (G) The amount of internalized Rhodamine-labeled DENV in B16 cells 
and GM95 cells as analyzed via an inverted fluorescence microscope.  
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GM3 is indispensable for DENV genome 
replication 
The replication of the positive-strand RNA of 
DENV is semi-conservative, and viral (-) strand RNA 
serves as a template for the synthesis of new (+) 
strand RNA. Therefore, the detection of viral (-) 
strand RNA is indicative for DENV replication. Total 
RNA was isolated from infected B16 and GM95 cells 
for indicated time points and transcribed into (-) 
cDNA with forward primer of DENV E gene. During 
6 to 24 hr postinfection, the amount of negative 
strands in infected B16 cells was significantly 
increased, but not in infected GM95 cells (Fig. 5A). In 
addition, qRT-PCR quantitation of negative strand 
RNA in B16 and GM95 cells at 24 hr postinfection also 
suggested that there was no detectable (-) strand 
subgenomic RNA in GM95 cells (Fig. 5B). In order to 
better understand the kinetics of 
DENV RNA replication, a wild-type DENV 
DNA-based replicon (DGL2) or a NS5 mutant 
replicon (DGL2 mut)[30] was transfected into B16 and 
GM95 cells. As shown in Fig. 5C and 5D, the DENV 
replicon replication was severely impaired in GM95 
cells. In line with this, when Soyasaponin-1 (Fig. 5E) 
and PPMP (Fig. 5F) was added to B16 cells, the DENV 
replicon replications were obviously decreased. 
Meanwhile, exogenous ganglioside GM3 added to 
GM95 cells partially restored the DENV replicon 
replication (Fig. 5G). These results demonstrated that 
GM3 was necessary for DENV genome replication. 
 
Figure 5. GM3 was indispensable for DENV genome replication. (A, B) Semi-quantified PCR (A) and qRT-PCR (B) analysis of negative strand RNA (-ssRNA) of DENV 
in infected B16 and GM95 cells. (C, D) The replication kinetics of DENV replicon (DGL2 or DGL2 mut) in B16 and GM95 cells. Cells supernatant was harvested at different time 
points and Gaussia luciferase was measured. (E, F) DGL2 replicon replication was inhibited by Soyasaponin-I (E) and PPMP (F) in B16 cells, individually. (G) Exogenous ganglioside 
GM3 added to GM95 cells partially restored the DGL2 replicon replication in GM95 cells. Results were expressed as the mean + the SEM. * p < 0.05 and ** p < 0.01 (t-test). 
Representative results from at least 3 independent experiments. 
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GM3 is associated with DENV replication 
complex 
Then we examined whether GM3 co-localized 
with DENV replication complex. Studies have been 
reported that DENV RNA replication takes place in 
replication complex (RC) on ER, which comprise the 
viral RNA template with the nonstructural proteins 
and presumably associated with virus-induced 
intracellular membrane structures. GM3 was stained 
in B16 cells with or without DENV infection and the 
ER structure were indicated by a YFP-labeled ER 
marker. As shown in Fig. 6A, GM3 is mainly located 
on the cell membrane. After DENV infection, the 
amount of GM3 significantly increased and some of 
them were localized on ER. Immunofluorescence 
staining also suggested that GM3 was partially 
colocalized with DENV NS4A, the non-structural 
protein that anchored the RC to ERs, in B16 cells (Fig. 
6B). These data suggested that GM3 colocalized with 
DENV replication complex in ER.  
Soyasaponin-I reduces the mortality rate of 
DENV infected suckling mice 
To test whether GM3 synthetase inhibitor 
soyasaponin-I could protect mice against DENV 
infection, 3- or 4-day-old suckling mice were 
inoculated intracerebrally with 100 PFU of DENV-2 
together with or without 15 μg soyasaponin-I, 
respectively. As shown in Fig. 7A, soyasaponin-I 
significantly reduced the mortality rate of suckling 
mice suffered with DENV infection. To test whether 
soyasaponin-I protect mice against DENV infection 
via inhibiting the viral replication, the DENV 
replication level in cerebral tissues were analyzed at 
day 2 and day 4 postinfection. As shown in Fig. 7B, 
the DENV replications in mouse brain were 
significantly impaired in soyasaponin-I treated mice. 
These data further suggested that GM3 was 
indispensable for DENV replication. 
 
 
Figure 6. GM3 was associated with DENV replication complex. (A) GM3 was co-localized with ER marker (YFP-KDEL) in DENV infected B16 cells. B16 cells were 
transfected with YFP-KDEL (an ER lumen protein as ER marker) and infected with DENV-2. After 48 hr, the cells were fixed. GM3 were stained mouse mAb followed by a TRITC 
labeled goat anti mouse IgM secondary Ab. The lower panel showed a detailed co-localization of GM3 and ER marker. (B) GM3 was colocalized with DENV NS4A in DENV 
infected B16 cells. B16 cells were infected with DENV-2 for 48 hrs. Then the cells were fixed and labeled with GM3 mouse mAb and NS4A rabbit Ab followed by fluorescence 
labeled secondary Abs. 
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Figure 7. Soyasaponin-I reduced the mortality rate of DENV infected suckling mice. (A) Survival rate of the suckling mice received intracerebral injection of 100 PFU 
of DENV-2 with or without 15 μg soyasaponin-I. Injected suckling mice were monitored daily for signs of illness until day 15. PBS or Soyasaponin-I was injected into suckling mice 
separately as the controls. Results were analyzed by Log-rank (Mantel-Cox) Test. ***p =0.0004. (B) Soyasaponin-I impaired the DENV replication in mouse brain. RNA was 
isolated from cerebral tissues of DENV-2 infected suckling mice with or without 15 μg soyasaponin-I at day 2 and day 4 postinfection. And the qRT-PCR was performed as 
described before. Results were expressed as the mean + the SEM. * p < 0.05 and ** p < 0.01 (t-test).Representative results from at least 3 independent experiments. 
 
Discussion 
GSLs are amphipathic lipids consisting of 
oligosaccharide and ceramide moieties. Ceramide, the 
common precursor of GSLs, is synthesized at the 
membranes of the ER. Newly synthesized ceramide 
transports from ER to the trans-Golgi regions, where 
it is converted to the most GSLs by 
glycosyltransferases. Finally, the de novo biosynthesis 
of GSLs reaches the plasma membrane via vesicular 
exocytotic membrane flow[19]. Viruses are not 
capable of replicating themselves independently, and 
must utilize host cell cofactors to facilitate its entry, 
replication, assembly and budding of virions. Among 
the host factors required by viruses, lipids like GSLs, 
play important roles in viral infection [20, 21]. The 
vast majority of articles showed that viruses exploit 
GSLs for viral binding, entry, assembly or release. For 
example, HIV-1 entry to CD4+ T cells via its envelope 
protein gp120 recognizes of CD4 on target cells, this 
interaction gives rise to a conformational change in 
gp120 third variable loop (V3) that allow for binding 
to GalCer, globotriaosylceramide (Gb3) and GM3. In 
addition, GalCer can support HIV entry into non-CD4 
expressing cells through binding to gp120 [22, 34-36]. 
Several members of the polyomavirus (Py), such as 
simian virus 40 (SV40), BK virus and Py viruses, also 
bind to specific gangliosides (sialic acid-containing 
GSLs) on cell membrane to cause infection[23]. In the 
case of virus budding, HIV-1 preferentially buds from 
GSL-enriched lipid microdomains on the plasma 
membrane. The HIV-1 virions contain higher levels of 
GM3 and boosts virus capture by mature dendritic 
cells (MDCs)[37]. However, the distinct role of GSLs 
in the DENV life cycle is still unclear. 
In the present study, we discovered that DENV 
infection severely impaired in GSL deficient GM95 
cells when compared with wild type B16 cells. 
Interestingly, DENV binding and entry were not 
affected in GM95 cells, suggesting that GSLs were not 
necessary for virus binding and endocytosis. 
However, Chie Aoki and colleagues reported that 
DENV-2 could recognize the neutral GSLs nLc4Cer 
(Galβ1-4GlcNAcβ1-3Galβ1-4Glcβ1-1’Cer) and L-3 
(GlcNAcβ1-3Manβ1-4Glcβ1-1’Cer) expressed on the 
cell surface of DENV-susceptible cells[38]. Whether 
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those specific GSLs were involved in DENV infection 
are still unknown. In our study, we focused on the 
role of GM3, the most dominant GSL in B16 cells. 
Actually, we did not detect any Gb3 and LC3 in B16 
cells by mass spectrometry. We found that GM3 was 
not required for DENV binding and endocytosis. 
To test whether GM3 play a role in DENV 
genome replication, DNA-based DENV replicon 
DGL-2 and DGL-2 mut[30] were used to assess the 
dynamic replication of DENV in B16 and GM95 cells. 
Without any binding or entry issue, transfected 
DENV replicon replicated much more efficiently in 
B16 cells compared to GM95 cells. Replication of 
DENV RNA occurs in ER membrane–associated 
replication complex (RC) composed of viral replicase 
proteins, viral RNA and other host factors [10, 39]. 
Subcellular colocalization analysis showed that GM3 
colocalized with the DENV NS4A, NS3 and ER 
marker in DENV infected B16 cells, suggesting that 
GSLs may participate in organization of DENV RCs. 
Recently, GSLs were reported to play a key role in 
Hepatitis C virus (HCV) replication. Knockdown of 
four-phosphate adaptor protein 2 (FAPP2) could 
attenuate HCV infectivity and impede HCV RNA 
replication. In addition, HCV increased LacCer and 
Gb3 levels, and addition of these lipids to 
FAPP2-depleted cells partially rescued 
replication[14]. The results were in line with our 
findings that GM3, a major subtype of GSLs, was 
indispensable for DENV genome replication. 
Although both HCV and DENV belong to the family 
Flaviviridae, the replication of DENV shows significant 
difference from that of HCV[10]. DENV’s NS4A 
induced rearrangements of the ER membranes after 
infection [40]. Electron tomography and 
three-dimensional reconstructions analyzes showed 
that DENV-induced ER-derived structure are termed 
vesicle packets and convoluted membranes, while 
HCV infection induces double-membrane 
vesicles[10].  
Up to date, the roles of GSLs during DENV 
infection are largely unknown. Our findings showed 
that GM3 was not required for DENV’s binding and 
entry, but indispensable for its replication. GM3 
synthetase inhibitor significantly reduced the 
mortality rate of DENV infected mice. Therefore, 
inhibiting GM3 biosynthesis could be a new strategy 
for control of DENV infection.  
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